BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28277286)

  • 1. Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma.
    Huang WJ; Tsai JH; Jeng YM
    J Formos Med Assoc; 2017 Jul; 116(7):549-553. PubMed ID: 28277286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma.
    Schmidt A; Braeuning A; Ruck P; Seitz G; Armeanu-Ebinger S; Fuchs J; Warmann SW; Schwarz M
    Toxicology; 2011 Mar; 281(1-3):7-14. PubMed ID: 21237236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
    Zhou S; Parham DM; Yung E; Pattengale P; Wang L
    Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma.
    Gupta K; Rane S; Das A; Marwaha RK; Menon P; Rao KL
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e320-8. PubMed ID: 22735888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.
    Wu JF; Chang HH; Lu MY; Jou ST; Chang KC; Ni YH; Chang MH
    J Biomed Sci; 2017 Aug; 24(1):62. PubMed ID: 28851352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study.
    Wang LL; Filippi RZ; Zurakowski D; Archibald T; Vargas SO; Voss SD; Shamberger RC; Davies K; Kozakewich H; Perez-Atayde AR
    Am J Surg Pathol; 2010 Mar; 34(3):287-99. PubMed ID: 20118773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
    Audard V; Grimber G; Elie C; Radenen B; Audebourg A; Letourneur F; Soubrane O; Vacher-Lavenu MC; Perret C; Cavard C; Terris B
    J Pathol; 2007 Jul; 212(3):345-52. PubMed ID: 17487939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal hepatic neoplasia in 3 children with APC gene mutation.
    Gupta A; Sheridan RM; Towbin A; Geller JI; Tiao G; Bove KE
    Am J Surg Pathol; 2013 Jul; 37(7):1058-66. PubMed ID: 23715166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.
    Bera G; Das RN; Roy P; Ghosh R; Islam N; Mishra PK; Chatterjee U
    Pediatr Surg Int; 2017 Sep; 33(9):961-970. PubMed ID: 28631020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
    Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
    Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
    Sempoux C; Gouw ASH; Dunet V; Paradis V; Balabaud C; Bioulac-Sage P
    Am J Surg Pathol; 2021 Apr; 45(4):477-487. PubMed ID: 33560657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic and prognostic value of SALL4 in hepatoblastoma.
    Zhou S; Venkatramani R; Gomulia E; Shillingford N; Wang L
    Histopathology; 2016 Nov; 69(5):822-830. PubMed ID: 27252091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
    Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
    Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
    Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
    Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High tricellulin expression is associated with better survival in human hepatoblastoma.
    Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
    Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
    Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
    Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma.
    Halász J; Holczbauer A; Páska C; Kovács M; Benyó G; Verebély T; Schaff Z; Kiss A
    Hum Pathol; 2006 May; 37(5):555-61. PubMed ID: 16647953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoblastoma--an attempt of histological subtyping on fine-needle aspiration material.
    Barwad A; Gupta N; Gupta K; Rajwanshi A; Marwaha RK; Rao KL; Dey P; Srinivasan R; Nijhawan R
    Diagn Cytopathol; 2013 Feb; 41(2):95-101. PubMed ID: 22362636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival.
    Schmidt A; Armento A; Bussolati O; Chiu M; Ellerkamp V; Scharpf MO; Sander P; Schmid E; Warmann SW; Fuchs J
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3169-3181. PubMed ID: 34235580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.